4D Molecular Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $261.8M
Liabilities Breakdown FY2022
Total Liabilities: $30.5M
Asset Breakdown
Total Assets: $261.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $52.4M | 20.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $22.3M | 8.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $187.2M | 71.5% |
Liabilities Breakdown
Total Liabilities: $30.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 10.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $27.2M | 89.1% |